165 related articles for article (PubMed ID: 32866811)
1. Comparative evaluation of SARS-CoV-2 IgG assays in India.
Chaudhuri S; Thiruvengadam R; Chattopadhyay S; Mehdi F; Kshetrapal P; Shrivastava T; Desiraju BK; Batra G; Kang G; Bhatnagar S;
J Clin Virol; 2020 Oct; 131():104609. PubMed ID: 32866811
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.
Johnson M; Wagstaffe HR; Gilmour KC; Mai AL; Lewis J; Hunt A; Sirr J; Bengt C; Grandjean L; Goldblatt D
J Clin Virol; 2020 Sep; 130():104572. PubMed ID: 32769024
[TBL] [Abstract][Full Text] [Related]
3. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
[TBL] [Abstract][Full Text] [Related]
4. Validation of a commercially available SARS-CoV-2 serological immunoassay.
Meyer B; Torriani G; Yerly S; Mazza L; Calame A; Arm-Vernez I; Zimmer G; Agoritsas T; Stirnemann J; Spechbach H; Guessous I; Stringhini S; Pugin J; Roux-Lombard P; Fontao L; Siegrist CA; Eckerle I; Vuilleumier N; Kaiser L;
Clin Microbiol Infect; 2020 Oct; 26(10):1386-1394. PubMed ID: 32603801
[TBL] [Abstract][Full Text] [Related]
5. Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays.
Rikhtegaran Tehrani Z; Saadat S; Saleh E; Ouyang X; Constantine N; DeVico AL; Harris AD; Lewis GK; Kottilil S; Sajadi MM
PLoS One; 2020; 15(11):e0237828. PubMed ID: 33137138
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
Beavis KG; Matushek SM; Abeleda APF; Bethel C; Hunt C; Gillen S; Moran A; Tesic V
J Clin Virol; 2020 Aug; 129():104468. PubMed ID: 32485620
[TBL] [Abstract][Full Text] [Related]
7. Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2.
Theel ES; Harring J; Hilgart H; Granger D
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32513859
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity.
Styer LM; Hoen R; Rock J; Yauney E; Nemeth K; Bievenue R; Parker MM
Microbiol Spectr; 2021 Sep; 9(1):e0013421. PubMed ID: 34319133
[TBL] [Abstract][Full Text] [Related]
9. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J
J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945
[TBL] [Abstract][Full Text] [Related]
10. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
Bryan A; Pepper G; Wener MH; Fink SL; Morishima C; Chaudhary A; Jerome KR; Mathias PC; Greninger AL
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381641
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals.
Wang H; Ai J; Loeffelholz MJ; Tang YW; Zhang W
Emerg Microbes Infect; 2020 Dec; 9(1):2200-2211. PubMed ID: 32962560
[TBL] [Abstract][Full Text] [Related]
12. AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.
Sil BK; Jamiruddin MR; Haq MA; Khondoker MU; Jahan N; Khandker SS; Ali T; Oishee MJ; Kaitsuka T; Mie M; Tomizawa K; Kobatake E; Haque M; Adnan N
Int J Nanomedicine; 2021; 16():4739-4753. PubMed ID: 34267520
[TBL] [Abstract][Full Text] [Related]
13. Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.
Ayouba A; Thaurignac G; Morquin D; Tuaillon E; Raulino R; Nkuba A; Lacroix A; Vidal N; Foulongne V; Le Moing V; Reynes J; Delaporte E; Peeters M
J Clin Virol; 2020 Aug; 129():104521. PubMed ID: 32623350
[TBL] [Abstract][Full Text] [Related]
14. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Ripperger TJ; Uhrlaub JL; Watanabe M; Wong R; Castaneda Y; Pizzato HA; Thompson MR; Bradshaw C; Weinkauf CC; Bime C; Erickson HL; Knox K; Bixby B; Parthasarathy S; Chaudhary S; Natt B; Cristan E; El Aini T; Rischard F; Campion J; Chopra M; Insel M; Sam A; Knepler JL; Capaldi AP; Spier CM; Dake MD; Edwards T; Kaplan ME; Scott SJ; Hypes C; Mosier J; Harris DT; LaFleur BJ; Sprissler R; Nikolich-Žugich J; Bhattacharya D
Immunity; 2020 Nov; 53(5):925-933.e4. PubMed ID: 33129373
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
Burbelo PD; Riedo FX; Morishima C; Rawlings S; Smith D; Das S; Strich JR; Chertow DS; Davey RT; Cohen JI
J Infect Dis; 2020 Jun; 222(2):206-213. PubMed ID: 32427334
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different serological assays for SARS-CoV-2 in real life.
Brochot E; Demey B; Handala L; François C; Duverlie G; Castelain S
J Clin Virol; 2020 Sep; 130():104569. PubMed ID: 32769023
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Multiplex Bead Assay against Single-Target Assays for Detection of IgG Antibodies to SARS-CoV-2.
Mitchell KF; Carlson CM; Nace D; Wakeman BS; Drobeniuc J; Niemeyer GP; Werner B; Hoffmaster AR; Satheshkumar PS; Schuh AJ; Udhayakumar V; Rogier E
Microbiol Spectr; 2022 Jun; 10(3):e0105422. PubMed ID: 35647696
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
Wellinghausen N; Plonné D; Voss M; Ivanova R; Frodl R; Deininger S
J Clin Virol; 2020 Sep; 130():104542. PubMed ID: 32707511
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Coronavirus Antibody Among First Responders in Lubbock, Texas.
Iwuji K; Islam E; Berdine G; Nugent K; Test V; Tijerina A
J Prim Care Community Health; 2020; 11():2150132720971390. PubMed ID: 33161808
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Murhekar MV; Bhatnagar T; Selvaraju S; Rade K; Saravanakumar V; Vivian Thangaraj JW; Kumar MS; Shah N; Sabarinathan R; Turuk A; Anand PK; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Rangaraju C; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Salim Khan SM; Haq I; Kumar MS; Laxmaiah A; Madhuka ; Mahapatra A; Mitra A; Nirmala AR; Pagdhune A; Qurieshi MA; Ramarao T; Sahay S; Sharma YK; Shrinivasa MB; Shukla VK; Singh PK; Viramgami A; Wilson VC; Yadav R; Girish Kumar CP; Luke HE; Ranganathan UD; Babu S; Sekar K; Yadav PD; Sapkal GN; Das A; Das P; Dutta S; Hemalatha R; Kumar A; Narain K; Narasimhaiah S; Panda S; Pati S; Patil S; Sarkar K; Singh S; Kant R; Tripathy S; Toteja GS; Babu GR; Kant S; Muliyil JP; Pandey RM; Sarkar S; Singh SK; Zodpey S; Gangakhedkar RR; S Reddy DC; Bhargava B
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):48-60. PubMed ID: 32952144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]